FDA Advisory Panel Cautiously Endorses Abbott Xience V Drug-Eluting Stent

FDA's Circulatory System Devices panel overwhelmingly endorsed PMA approval of Abbott's Xience V everolimus-eluting, despite reservations about its long-term safety